INCIDENCE, PATHOLOGY, AND RECURRENCE OF PITUITARY-ADENOMAS - STUDY OF 647 UNSELECTED SURGICAL CASES

被引:43
作者
TERADA, T [1 ]
KOVACS, K [1 ]
STEFANEANU, L [1 ]
HORVATH, E [1 ]
机构
[1] UNIV TORONTO,ST MICHAELS HOSP,DEPT PATHOL,TORONTO,ON M5S 1A1,CANADA
关键词
PITUITARY ADENOMAS; INCIDENCE; HISTOLOGIC CHARACTERISTICS; RECURRENCE; REMISSION PERIODS;
D O I
10.1007/BF02738730
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The incidence of various types of unselected pituitary adenomas based on correlation of pathologic and clinical data was assessed. We investigated 647 cases of unselected pituitary adenomas, which were surgically removed between 1980 and 1993. All cases were examined by immunohistochemistry and electron microscopy. The mean age of patients was 44.0 years with 40.0 years for women (55.2%) and 49.1 years for men (44.8%). Age distribution indicated a remarkable sex difference: 52.4% of women and 26.8% of men were between 21 and 40 years at the time of surgery. Based on immunohistochemistry and electron microscopy, prolactin (PRL) cell adenomas represented 26.3% of tumors, growth hormone (GH) cell adenomas 12.5%, adrenocorticotrophic hormone (ACTH) cell adenomas 12.4%, oncocytomas 12.4%, and gonadotroph cell adenomas 9.4%. Seventy-three percent of the prolactinomas occurred in women and 73.8% of the oncocytomas were found in men. The incidence of pediatrics pituitary adenomas was 4.6%. All 647 cases were followed up; the mean follow-up period was 96.6 months. In 40 patients (6.2%), the adenoma recurred. Recurrence was common in functioning ACTH cell adenomas (8 cases: 9.5%) followed by silent adenomas (7 cases: 25.9%). Recurrence was noted after 2-96 months (average 28.7 months) following surgery. The shortest remission period was found in a patient with oncocytoma followed by a patient with prolactinoma.
引用
收藏
页码:301 / 310
页数:10
相关论文
共 32 条
[1]  
BENEDICT R, 1981, SURG NEUROL, V15, P249
[2]   MICROADENOMAS OF THE PITUITARY AND ABNORMAL SELLAR TOMOGRAMS IN AN UNSELECTED AUTOPSY SERIES [J].
BURROW, GN ;
WORTZMAN, G ;
REWCASTLE, NB ;
HOLGATE, RC ;
KOVACS, K .
NEW ENGLAND JOURNAL OF MEDICINE, 1981, 304 (03) :156-158
[3]  
FAGLIA G, 1993, ACTA ENDOCRINOL-COP, V129, P1
[4]   EPIDEMIOLOGY OF PITUITARY-ADENOMAS [J].
GOLD, EB .
EPIDEMIOLOGIC REVIEWS, 1981, 3 :163-183
[5]   DEPOT-BROMOCRIPTINE TREATMENT FOR PROLACTINOMAS AND ACROMEGALY [J].
GROSSMAN, A ;
ROSS, R ;
WASS, JAH ;
BESSER, GM .
CLINICAL ENDOCRINOLOGY, 1986, 24 (02) :231-238
[6]   PEDIATRIC PITUITARY-TUMORS [J].
HADDAD, SF ;
VANGILDER, JC ;
MENEZES, AH .
NEUROSURGERY, 1991, 29 (04) :509-514
[7]   PITUITARY-GLAND [J].
HORVATH, E ;
KOVACS, K .
PATHOLOGY RESEARCH AND PRACTICE, 1988, 183 (02) :129-142
[8]  
HORVATH E, 1986, SEMIN DIAGN PATHOL, V3, P4
[9]   A NOVEL TYPE OF PITUITARY-ADENOMA - MORPHOLOGICAL FEATURES AND CLINICAL CORRELATIONS [J].
HORVATH, E ;
KOVACS, K ;
SMYTH, HS ;
KILLINGER, DW ;
SCHEITHAUER, BW ;
RANDALL, R ;
LAWS, ER ;
SINGER, W .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1988, 66 (06) :1111-1118
[10]  
Horvath E, 1991, FUNCTIONAL ENDOCRINE, P245